Journal for ImmunoTherapy of Cancer, 8(2):e001607. BioMed Central Ltd. Journal for Immunotherapy of Cancer Journal for ImmunoTherapy of Cancer, 8(2). BMJ PUBLISHING GROUP Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer Journal for ImmunoTherapy of Cancer, 7(1):149. BioMed Central Ltd. Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
HemaSphere, 3(5) HemaSphere HemaSphere, 3(5):e285. Wolters Kluwer Health HemaSphere, 3(5):UNSP e285. Wolters Kluwer Health HemaSphere, Vol 3, Iss 5 (2019) Kalin, B, Ter Borg, M, Wijers, R, Somers, J A E, Van Der Holt, B, Van Bergen, C A M, Petersen, E J, Kuball, J, Meijer, E, Schaap, N P M, Zeerleder, S S, Broers, A E, Braakman, E, Frederik Falkenburg, J H, Lamers, C H J & Cornelissen, J J 2019, ' Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients : A Phase II Study Focusing on the Mechanism of Graft Predominance ', HemaSphere, vol. 3, no. 5, e285 . https://doi.org/10.1097/HS9.0000000000000285